Synapse - Mikhail Roshal

Results (229)

Next-generation sequencing-based assay shows high clonal characterization success rate for plasma cell neoplasms, and concordance with flow cytometry in minimal residual disease detection

Meeting Abstract

Ho, C.; Syed, M.; Roshal, M.; Petrova-Drus, K.; Moung, C.; Yao, J. J.; Yu, W.; Maciag, L.; Benayed, R.; Hultcrantz, M.; more...
Blood (2018)

Fulltext@MSK | Save

A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia

Journal Article

Forlenza, C. J.; Zhang, Y.; Yao, J.; Benayed, R.; Steinherz, P.; Ramaswamy, K.; Kessel, R.; Roshal, M.; Shukla, N.
Cold Spring Harbor Molecular Case Studies (2018)

Fulltext@MSK | Save

Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition

Journal Article

Harding, J. J.; Lowery, M. A.; Shih, A. H.; Schvartzman, J. M.; Hou, S.; Famulare, C.; Patel, M.; Roshal, M.; Do, R. K.; Zehir, A.; more...
Cancer Discovery (2018)

Fulltext@MSK | Save

PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation

Journal Article

Xiao, W.; Bharadwaj, M.; Levine, M.; Farnhoud, N.; Pastore, F.; Getta, B. M.; Hultquist, A.; Famulare, C.; Medina, J. S.; Patel, M. A.; more...
Blood Advances (2018)

Fulltext@MSK | Save

Clinical implementation of T-cell clonality testing by next-generation sequencing: Improved detection sensitivity and reliability in initial diagnosis and minimal residual disease detection of T-cell malignancies

Meeting Abstract

Yao, J.; Syed, M.; Yu, W.; Maciag, L.; Ho, C.; Petrova-Drus, K.; Moung, C.; Zehir, A.; Roshal, M.; Rosado, A.; more...
Journal of Molecular Diagnostics (2018)

Fulltext@MSK | Save

Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations

Journal Article

Mi, X.; Griffin, G.; Lee, W.; Patel, S.; Ohgami, R.; Ok, C. Y.; Wang, S.; Geyer, J. T.; Xiao, W.; Roshal, M.; more...
American Journal of Hematology (2018)

Fulltext@MSK | Save

Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies

Journal Article

Taylor, J.; Pavlick, D.; Yoshimi, A.; Marcelus, C.; Chung, S. S.; Hechtman, J. F.; Benayed, R.; Cocco, E.; Durham, B. H.; Bitner, L.; more...
Journal of Clinical Investigation (2018)

Fulltext@MSK | Save

JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation

Journal Article

Xiao, W.; Rampal, R.; Zhang, Y.; Cimera, R.; Jungbluth, A. A.; Arcila, M.; Roshal, M.; Park, D. C.
Leukemia (2018)

Fulltext@MSK | Save

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Journal Article

Intlekofer, A. M.; Shih, A. H.; Wang, B.; Nazir, A.; Rustenburg, A. S.; Albanese, S. K.; Patel, M.; Famulare, C.; Correa, F. M.; Takemoto, N.; more...
Nature (2018)

Fulltext@MSK | Save

Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms

Journal Article

Gao, Q.; Yellapantula, V.; Fenelus, M.; Pichardo, J.; Wang, L.; Landgren, O.; Dogan, A.; Roshal, M.
Modern Pathology (2018)

Fulltext@MSK | Save